Johnson & Johnson Innovation
Latin America Challenge
register your proposal
Johnson & Johnson is the largest health company in the world, with focus on pharmaceutical therapies, vaccines, medical devices and consumer healthcare products (Johnson's Baby®, Neutrogena®, Tylenol®, Listerine®, Carefree®, Band-Aid®). We believe a good idea can come from anywhere, and it's our goal to find new and innovative technologies that provide solutions to people from around the world. Working together, we can spark the next great idea that could change the trajectory of human health.
About the Challenge
Are you an early stage entrepreneur or start-up company from Brazil or other Latin America country with a game-changing, transformative healthcare innovation or technology?
Do you want the opportunity to engage and partner with Johnson & Johnson experts and be a potential resident at a JLabs incubator?
Johnson & Johnson lnnovation is launching the Latin America Challenge 2019
We are looking for technologies or solutions across all stages (prototype, pre-clinical, clinical, commercial) that are advancing healthcare discovery & development in:
With applications to:
Consumer Health
Skin Health
Sun Care
Acne
Pain
Allergy
Smoking Cessation
Women´s Health
Pharmaceuticals
Oncology
Neuroscience
Cardiology
Infectious Diseases
Vaccines
Immunology
Pulmonary Hypertension
Metabolic Diseases
Medical Devices
Surgical Oncology and Cardiology
Obesity
Osteoarthritis
Osteoporosis
Schedule
Released: September 10, 2019.
End of entries: December 10, 2019.
Winner announcement: OIWeek 2020, Sao Paulo, Brazil.
FAQ
1. Where do I apply?
https://startup.openstartups.net/login/?eventcode=jnj_lachallenge
2. What stage and locations are companies eligible to apply?
The challenge is open to any incorporated companies from Latin America, which are developing healthcare solutions in any stage (prototype, pre-clinical, clinical, commercial).
3. Is it ok if some of the information I submit is confidential?
Do not submit confidential information. Only non-confidential information should be submitted.
4. What happens with IP?
As this is a no strings attached arrangement, the IP remains with the inventors.
5. When is the application deadline?
December 10th 2019.
6. When and where will the winners be announced?
TBD (OIWeek 2020, Sao Paulo, Brazil).
7. What is being awarded and to how many companies?
Opportunity to engage with J&J experts, potential for residency at a JLabs incubator, for one company.
8. What facilities will be available at JLabs? And for how many people?
Lab space and a workstation/office space for 2 people max. lt is required to sign a License Agreement for JLabs before being granted access to the bench and workstation. Johnson & Johnson lnnovation reserves the right to review and approve any finalist and may choose to refuse and/or revoke any such grant of access to JLabs, at any time, acting in its sole and absolute discretion. More information at jlabs.jnjinnovation.com.
9. Will J&J pay for R&D costs, living costs in the selected region and relocate family?
No.
10. Do you help with immigration issues?
Applicants need to do their own research or talk to their own legal counsel to ensure they abide by the rules in place governing acceptable activities for temporary business visitors in the country. We also do not sponsor applicants as the facilities provided are simply a platform for them to use while they conduct their own acceptable business practices.
11. lf selected, when is move-in?
To be negotiated.
If we can help you with any other information please e-mail us at helpme@openstartups.net.
